Among the AD risk genes identified beyond the classical APP, PSEN1/2, and ApoE, triggering receptor expressed on myeloid cells (TREM2) has a relatively large impact on AD risk compared to other common variants, with odds ratios ranging from 2 to 4 in carriers of the R47H mutation [122,123]. The gene discussed is APP; the disease is Alzheimer disease.